Generic name: |
ixekizumab |
|
---|---|---|
Strength: |
80 mg/1 mL |
|
Form: |
solution for subcutaneous injection in a pre-filled syringe or pre-filled auto-injector |
Special Authority criteria |
Approval period |
---|---|
For the treatment of moderate to severe Plaque Psoriasis, according to criteria detailed in HLTH 5380, when prescribed by a dermatologist. |
First approval: 12 weeks Renewal: 1 year |
For the treatment of moderate to severe Psoriatic Arthritis, according to criteria detailed in HLTH 5360 (Initial/Switch) or HLTH 5361 (renewal), and when prescribed by a rheumatologist. |
First approval: 1 year Renewal: 1 year |